000 01188 a2200325 4500
005 20250512055545.0
264 0 _c19860610
008 198606s 0 0 eng d
022 _a0278-5846
024 7 _a10.1016/0278-5846(86)90047-3
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFleischhacker, W W
245 0 0 _aMemantine in the treatment of senile dementia of the Alzheimer type.
_h[electronic resource]
260 _bProgress in neuro-psychopharmacology & biological psychiatry
_c1986
300 _a87-93 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Randomized Controlled Trial
650 0 4 _aAged
650 0 4 _aAlzheimer Disease
_xdrug therapy
650 0 4 _aAmantadine
_xanalogs & derivatives
650 0 4 _aClinical Trials as Topic
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMemantine
_xadverse effects
650 0 4 _aRandom Allocation
700 1 _aBuchgeher, A
700 1 _aSchubert, H
773 0 _tProgress in neuro-psychopharmacology & biological psychiatry
_gvol. 10
_gno. 1
_gp. 87-93
856 4 0 _uhttps://doi.org/10.1016/0278-5846(86)90047-3
_zAvailable from publisher's website
999 _c3523690
_d3523690